CompletedNot Applicable

Combining Broad Based Light (BBL), Fractionated 1927 (MOXI) and Dual Wavelength 2940/1470 (HALO)

United States15 participantsStarted 2024-01-01

Plain-language summary

This is a single-site, non-randomized, non-controlled study at UT Southwestern Medical Center at Dallas in the Department of Plastic Surgery. The study is designed to follow up to 15 consenting subjects who may receive up to 2 BBL/MOXI/HALO treatments under an IRB approved protocol.

Who can participate

Age range

20 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Healthy male and female adults between 20-75 years of age
. Fitzpatrick skin type 1-4
. Individual deemed by the Investigator to benefit from skin resurfacing treatment(s)
. Individuals willing to withhold aesthetic therapies that may potentially impact results to the treatment areas for the duration of the study
. Women of childbearing potential:
.1. will be asked to agree to a pregnancy test before their screening visit in clinic 5.2. must use an acceptable method of birth control
. Individuals who can read, speak, write and understand English and who are willing to provide written informed consent.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Brown Spots at 1 Month From Baseline (Single Treatment Group)

Timeframe: Baseline, 1 Month

Change in Brown Spots at 3 Months From Baseline (Single Treatment Group)

Timeframe: Baseline, 3 Months

Change in Brown Spots at 1 Month From Baseline (Double Treatment Group)

Timeframe: Baseline, 1 Month

Change in Brown Spots at 3 Months From Baseline (Double Treatment Group)

Timeframe: Baseline, 3 Months

Change in Pores at 1 Month From Baseline (Single Treatment Group)

Timeframe: Baseline, 1 Month

Change in Pores at 3 Months From Baseline (Single Treatment Group)

Timeframe: Baseline, 3 Months

Change in Pores at 1 Month From Baseline (Double Treatment Group)

Timeframe: Baseline, 1 Month

Trial details

NCT IDNCT06091215

SponsorUniversity of Texas Southwestern Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-11

Results submitted2025-06-04

View on ClinicalTrials.gov More Pigment Skin trials

Who can participate

Age range

20 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Healthy male and female adults between 20-75 years of age
. Fitzpatrick skin type 1-4
. Individual deemed by the Investigator to benefit from skin resurfacing treatment(s)
. Individuals willing to withhold aesthetic therapies that may potentially impact results to the treatment areas for the duration of the study
. Women of childbearing potential:
.1. will be asked to agree to a pregnancy test before their screening visit in clinic 5.2. must use an acceptable method of birth control
. Individuals who can read, speak, write and understand English and who are willing to provide written informed consent.

What they're measuring

Change in Brown Spots at 1 Month From Baseline (Single Treatment Group)

Timeframe: Baseline, 1 Month

Change in Brown Spots at 3 Months From Baseline (Single Treatment Group)

Timeframe: Baseline, 3 Months

Change in Brown Spots at 1 Month From Baseline (Double Treatment Group)

Timeframe: Baseline, 1 Month

Change in Brown Spots at 3 Months From Baseline (Double Treatment Group)

Timeframe: Baseline, 3 Months

Change in Pores at 1 Month From Baseline (Single Treatment Group)

Timeframe: Baseline, 1 Month

Change in Pores at 3 Months From Baseline (Single Treatment Group)

Timeframe: Baseline, 3 Months

Change in Pores at 1 Month From Baseline (Double Treatment Group)

Timeframe: Baseline, 1 Month

Combining Broad Based Light (BBL), Fractionated 1927 (MOXI) and Dual Wavelength 2940/1470 (HALO)

Plain-language summary

Who can participate

Inclusion criteria

Questions worth asking your doctor

Questions for the trial coordinator

What they're measuring

Trial details

Combining Broad Based Light (BBL), Fractionated 1927 (MOXI) and Dual Wavelength 2940/1470 (HALO)

Plain-language summary

Who can participate

Inclusion criteria

Questions worth asking your doctor

Questions for the trial coordinator

What they're measuring

Trial details

Exclusion criteria